Consider MadeMed for explicit day-based plan charges
The current selectors show $179 per 30 days for semaglutide injection and $249 for tirzepatide injection or sublingual tablets. The longest plans charge $1,718 or $2,390 every 360 days; their lower equivalents are not monthly debits. This makes the plan charge visible, but the product pages' $20/$30 consultation fees conflict with included-consultation and full-refund wording. Confirm that bill and the actual usable supply before prepaying; the terms reject prorated refunds.
Read the MadeMed review →